Chad D Paavola, Age 546024 Arbour Ave, Minneapolis, MN 55436

Chad Paavola Phones & Addresses

6024 Arbour Ave, Minneapolis, MN 55436

10329 Power Dr, Carmel, IN 46033 (650) 996-4443

1140 Tangerine Way, Sunnyvale, CA 94087 (408) 746-0181

Durham, NC

Mountain View, CA

Woodside, CA

Berkeley, CA

El Cerrito, CA

Show more

Social networks

Chad D Paavola

Linkedin

Work

Company: Nasa ames research center Jun 2001 to Mar 2012 Position: Research scientist

Education

School / High School: University of California, Berkeley 1993 to 1999 Specialities: Biology

Skills

Biotechnology

Industries

Research

Mentions for Chad D Paavola

Resumes and CV

Resumes

Chad Paavola Photo 1

Research Fellow

Location:
Edina, MN
Industry:
Research
Work:
Nasa Ames Research Center Jun 2001 - Mar 2012
Research Scientist
Eli Lilly and Company Jun 2001 - Mar 2012
Research Fellow
Duke University May 1999 - May 2001
Postdoctoral Associate
Education:
University of California, Berkeley 1993 - 1999
Edina High School
Skills:
Biotechnology

Publications

Us Patents

Ordered Biological Nanostructures Formed From Chaperonin Polypeptides

US Patent:
7816491, Oct 19, 2010
Filed:
Nov 8, 2002
Appl. No.:
10/494853
Inventors:
Jonathan D. Trent - Watsonville CA, US
R. Andrew McMillan - San Francisco CA, US
Hiromi Kagawa - Sunnyvale CA, US
Chad D. Paavola - Mountain View CA, US
Assignee:
The United States of America as represented by the Administrator of the National Aeronautics and Space Administration - Washington DC
International Classification:
C07K 14/00
A61K 38/00
US Classification:
530350, 514 2, 977773
Abstract:
The following application relates to nanotemplates, nanostructures, nanoarrays and nanodevices formed from wild-type and mutated chaperonin polypeptides, methods of producing such compositions, methods of using such compositions and particular chaperonin polypeptides that can be utilized in producing such compositions.

Versatile Platform For Nanotechnology Based On Circular Permutations Of Chaperonin Protein

US Patent:
2006008, Apr 20, 2006
Filed:
Aug 1, 2005
Appl. No.:
11/194991
Inventors:
Chad Paavola - Mountain View CA, US
Jonathan Trent - Watsonville CA, US
Suzanne Chan - Oakland CA, US
Yi-Fen Li - Sunnyvale CA, US
R. McMillan - San Francisco CA, US
Hiromi Kagawa - Sunnyvale CA, US
International Classification:
C07K 14/195
C07H 21/04
C12P 21/06
C12N 15/74
C12N 1/21
US Classification:
530350000, 435069100, 435252300, 435320100, 536023700
Abstract:
The present invention provides chaperonin polypeptides which are modified to include N-terminal and C-terminal ends that are relocated from the central pore region to various different positions in the polypeptide which are located on the exterior of the folded modified chaperonin polypeptide. In the modified chaperonin polypeptide, the naturally-occurring N-terminal and C-terminal ends are joined together directly or with an intervening linker peptide sequence. The relocated N-terminal or C-terminal ends can be covalently joined to, or bound with another molecule such as a nucleic acid molecule, a lipid, a carbohydrate, a second polypeptide, or a nanoparticle. The modified chaperonin polypeptides can assemble into double-ringed chaperonin structures. Further, the chaperonin structures can organize into higher order structures such as nanofilaments or nanoarrays which can be used to produce nanodevices and nanocoatings.

Rapid-Acting Insulin Compositions

US Patent:
2020007, Mar 12, 2020
Filed:
May 31, 2018
Appl. No.:
16/615894
Inventors:
- Indianapolis IN, US
Chad Donald Paavola - Carmel IN, US
International Classification:
A61K 38/28
A61K 47/30
A61K 47/02
A61K 47/10
A61P 3/10
A61K 9/00
Abstract:
The invention is a composition of insulin or insulin analog that has faster pharmacokinetic action than commercial formulations of rapid-onset insulin analog products.

Rapid-Acting Insulin Compositions

US Patent:
2019023, Aug 1, 2019
Filed:
May 14, 2018
Appl. No.:
15/978329
Inventors:
- Indianapolis IN, US
Chi A. Nguyen - Fisher IN, US
Chad D. Paavola - Carmel IN, US
Virender Kumar Sarin - Carmel IN, US
Nanette Elizabeth Schulte - Indianapolis IN, US
Ranajoy Majumdar - Indianapolis IN, US
International Classification:
A61K 38/28
A61K 47/02
A61K 47/10
A61K 47/12
A61P 3/10
Abstract:
The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.

Rapid-Acting Insulin Compositions

US Patent:
2018014, May 24, 2018
Filed:
Jan 11, 2018
Appl. No.:
15/868272
Inventors:
- Indianapolis IN, US
Michael Edward Christe - Pendleton IN, US
Thomas Andrew Hardy - Carmel IN, US
Ranajoy Majumdar - Indianapolis IN, US
Chi Arch Nguyen - Fishers IN, US
Chad Donald Paavola - Indianapolis IN, US
Virender Kumar Sarin - Carmel IN, US
Nanette Elizabeth Schulte - Indianapolis IN, US
International Classification:
A61K 38/28
A61K 47/10
A61K 31/192
A61K 47/12
A61K 9/00
A61K 47/02
A61K 47/34
Abstract:
The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Rapid-Acting Insulin Compositions

US Patent:
2017005, Mar 2, 2017
Filed:
Aug 19, 2016
Appl. No.:
15/241412
Inventors:
- Indianapolis IN, US
Michael Edward Christe - Pendleton IN, US
Thomas Andrew Hardy - Carmel IN, US
Ranajoy Majumdar - Indianapolis IN, US
Chi Arch Nguyen - Fishers IN, US
Chad Donald Paavola - Carmel IN, US
Virender Kumar Sarin - Carmel IN, US
Nanette Elizabeth Schulte - Indianapolis IN, US
International Classification:
A61K 38/28
A61K 47/02
A61K 47/10
A61K 47/12
Abstract:
The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Rapid-Acting Insulin Compositions

US Patent:
2016016, Jun 16, 2016
Filed:
Dec 9, 2015
Appl. No.:
14/963279
Inventors:
- INDIANAPOLIS IN, US
CHI A. NGUYEN - FISHERS IN, US
CHAD D. PAAVOLA - CARMEL IN, US
VIRENDER KUMAR SARIN - CARMEL IN, US
NANETTE ELIZABETH SCHULTE - INDIANAPOLIS IN, US
RANAJOY MAJUMDAR - INDIANAPOLIS IN, US
International Classification:
A61K 47/12
A61K 47/02
A61K 38/28
Abstract:
The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.